Re:High US health care spending explained by its high materi...
by arcticbull on Monday March 13, 2017 @04:07AM
(#13856023)
Based on conversations in other threads, it has been posited that it isn't the profit motive pushing that but rather the US governments' heavy investment in drug research [1], [2].
Canada doesn't have a big drug sector to the best of my knowledge though playing along, plenty of countries with socialized medicine do:
Denmark has Novo Nordisk.
Germany has Boeringer Ingelheim and Bayer.
Switzerland has Roche.
Astra/Zeneca is Swedish/British.
GlaxoSmithKlein is British.
Sanofi is French.
Novartis is Swiss.
Actually, of the top 10 by revenue, only two (Johnson and Johnson, and Pfizer, #1 and #3 respectively) are American. All the rest are European. Assuming based on the references that development has more to do with funding, I'm willing to bet the EU spends an awful lot.
Canada doesn't have a big drug sector to the best of my knowledge though playing along, plenty of countries with socialized medicine do:
Denmark has Novo Nordisk.
Germany has Boeringer Ingelheim and Bayer.
Switzerland has Roche.
Astra/Zeneca is Swedish/British.
GlaxoSmithKlein is British.
Sanofi is French.
Novartis is Swiss.
Actually, of the top 10 by revenue, only two (Johnson and Johnson, and Pfizer, #1 and #3 respectively) are American. All the rest are European. Assuming based on the references that development has more to do with funding, I'm willing to bet the EU spends an awful lot.
[1] http://abcnews.go.com/WNT/YourMoney/story?id=129651
[2] http://undsci.berkeley.edu/article/who_pays